000155574 001__ 155574
000155574 005__ 20240320115511.0
000155574 0247_ $$2pmc$$apmc:PMC8563628
000155574 0247_ $$2doi$$a10.1007/s00415-021-10568-9
000155574 0247_ $$2pmid$$apmid:33904966
000155574 0247_ $$2ISSN$$a0012-1037
000155574 0247_ $$2ISSN$$a0340-5354
000155574 0247_ $$2ISSN$$a0939-1517
000155574 0247_ $$2ISSN$$a1432-1459
000155574 0247_ $$2ISSN$$a1619-800X
000155574 0247_ $$2altmetric$$aaltmetric:104785111
000155574 0247_ $$2ISSN$$a0367-004x
000155574 0247_ $$2ISSN$$a0367-004X
000155574 037__ $$aDZNE-2021-00752
000155574 041__ $$aEnglish
000155574 082__ $$a610
000155574 1001_ $$aSchmidt, Nele$$b0
000155574 245__ $$aMemory enhancement by multidomain group cognitive training in patients with Parkinson's disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial.
000155574 260__ $$aBerlin$$bSpringer$$c2021
000155574 3367_ $$2DRIVER$$aarticle
000155574 3367_ $$2DataCite$$aOutput Types/Journal article
000155574 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1636454870_20945
000155574 3367_ $$2BibTeX$$aARTICLE
000155574 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000155574 3367_ $$00$$2EndNote$$aJournal Article
000155574 500__ $$aISSN 1432-1459 not unique: **2 hits**.
000155574 520__ $$aMeta-analyses indicate positive effects of cognitive training (CT) in patients with Parkinson's disease (PD), however, most previous studies had small sample sizes and did not evaluate long-term follow-up. Therefore, a multicenter randomized controlled, single-blinded trial (Train-ParC study) was conducted to examine CT effects in PD patients with mild cognitive impairment (PD-MCI). Immediately after CT, an enhancement of executive functions was demonstrated. Here, we present the long-term results 6 and 12 months after CT.At baseline, 64 PD-MCI patients were randomized to a multidomain CT group (n = 33) or to a low-intensity physical activity training control group (PT) (n = 31). Both interventions included 90 min training sessions twice a week for 6 weeks. 54 patients completed the 6 months (CT: n = 28, PT: n = 26) and 49 patients the 12 months follow-up assessment (CT: n = 25, PT: n = 24). Primary study outcomes were memory and executive functioning composite scores. Mixed repeated measures ANOVAs, post-hoc t tests and multiple regression analyses were conducted.We found a significant time x group interaction effect for the memory composite score (p = 0.006, η2 = 0.214), but not for the executive composite score (p = 0.967, η2 = 0.002). Post-hoc t tests revealed significant verbal and nonverbal memory improvements from pre-intervention to 6 months, but not to 12 months follow-up assessment in the CT group. No significant predictors were found for predicting memory improvement after CT.This study provides Class 1 evidence that multidomain CT enhances memory functioning in PD-MCI after 6 months but not after 12 months, whereas executive functioning did not change in the long-term.German Clinical Trials Register (ID: DRKS00010186), 21.3.2016 (The study registration is outlined as retrospective due to an administrative delay. The first patient was enrolled three months after the registration process was started. A formal confirmation of this process from the German Clinical Trials Register can be obtained from the authors.).
000155574 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000155574 542__ $$2Crossref$$i2021-04-27$$uhttps://creativecommons.org/licenses/by/4.0
000155574 542__ $$2Crossref$$i2021-04-27$$uhttps://creativecommons.org/licenses/by/4.0
000155574 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000155574 650_7 $$2Other$$aCognition
000155574 650_7 $$2Other$$aCognitive training
000155574 650_7 $$2Other$$aLong-term effects
000155574 650_7 $$2Other$$aMild cognitive impairment
000155574 650_7 $$2Other$$aNon-pharmacological intervention
000155574 650_7 $$2Other$$aParkinson’s disease
000155574 650_2 $$2MeSH$$aCognition
000155574 650_2 $$2MeSH$$aCognition Disorders
000155574 650_2 $$2MeSH$$aCognitive Dysfunction: etiology
000155574 650_2 $$2MeSH$$aCognitive Dysfunction: therapy
000155574 650_2 $$2MeSH$$aHumans
000155574 650_2 $$2MeSH$$aNeuropsychological Tests
000155574 650_2 $$2MeSH$$aParkinson Disease: complications
000155574 650_2 $$2MeSH$$aParkinson Disease: therapy
000155574 650_2 $$2MeSH$$aRetrospective Studies
000155574 7001_ $$aTödt, Inken$$b1
000155574 7001_ $$0P:(DE-2719)2000059$$aBerg, Daniela$$b2$$udzne
000155574 7001_ $$aSchlenstedt, Christian$$b3
000155574 7001_ $$aFolkerts, Ann-Kristin$$b4
000155574 7001_ $$aOphey, Anja$$b5
000155574 7001_ $$aDimenshteyn, Karina$$b6
000155574 7001_ $$aElben, Saskia$$b7
000155574 7001_ $$aWojtecki, Lars$$b8
000155574 7001_ $$0P:(DE-2719)2109499$$aLiepelt-Scarfone, Inga$$b9$$udzne
000155574 7001_ $$0P:(DE-2719)9000366$$aSchulte, Claudia$$b10$$udzne
000155574 7001_ $$0P:(DE-2719)2811919$$aSulzer, Patricia$$b11$$udzne
000155574 7001_ $$aEggers, Carsten$$b12
000155574 7001_ $$aKalbe, Elke$$b13
000155574 7001_ $$0P:(DE-HGF)0$$aWitt, Karsten$$b14$$eCorresponding author
000155574 77318 $$2Crossref$$3journal-article$$a10.1007/s00415-021-10568-9$$bSpringer Science and Business Media LLC$$d2021-04-27$$n12$$p4655-4666$$tJournal of Neurology$$v268$$x0340-5354$$y2021
000155574 773__ $$0PERI:(DE-600)1421299-7$$a10.1007/s00415-021-10568-9$$n12$$p4655-4666$$tJournal of neurology$$v268$$x0340-5354$$y2021
000155574 8564_ $$uhttps://link.springer.com/article/10.1007%2Fs00415-021-10568-9
000155574 8564_ $$uhttps://pub.dzne.de/record/155574/files/19590.pdf$$yOpenAccess
000155574 8564_ $$uhttps://pub.dzne.de/record/155574/files/19590.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000155574 909CO $$ooai:pub.dzne.de:155574$$popenaire$$pdnbdelivery$$pdriver$$pVDB$$popen_access
000155574 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2000059$$aExternal Institute$$b2$$kExtern
000155574 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2109499$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b9$$kDZNE
000155574 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000366$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b10$$kDZNE
000155574 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811919$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b11$$kDZNE
000155574 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000155574 9130_ $$0G:(DE-HGF)POF3-345$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vPopulation Studies and Genetics$$x0
000155574 9130_ $$0G:(DE-HGF)POF3-344$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vClinical and Health Care Research$$x1
000155574 9141_ $$y2021
000155574 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-12
000155574 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-12
000155574 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000155574 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-12
000155574 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NEUROL : 2021$$d2022-11-12
000155574 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-12
000155574 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-12
000155574 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000155574 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-12
000155574 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ NEUROL : 2021$$d2022-11-12
000155574 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-12
000155574 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2022-11-12$$wger
000155574 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-12
000155574 9201_ $$0I:(DE-2719)5000055$$kAG Berg$$lParkinson's Disease Genetics AG Berg$$x0
000155574 9201_ $$0I:(DE-2719)1210000$$kAG Gasser 1$$lParkinson Genetics$$x1
000155574 9201_ $$0I:(DE-2719)1240005$$kCore ICRU$$lCore ICRU$$x2
000155574 980__ $$ajournal
000155574 980__ $$aVDB
000155574 980__ $$aUNRESTRICTED
000155574 980__ $$aI:(DE-2719)5000055
000155574 980__ $$aI:(DE-2719)1210000
000155574 980__ $$aI:(DE-2719)1240005
000155574 9801_ $$aFullTexts
000155574 999C5 $$1R Monastero$$2Crossref$$9-- missing cx lookup --$$a10.1007/s00415-018-8800-4$$p1050 -$$tJ Neurol$$uMonastero R, Cicero CE, Baschi R, Davì M, Luca A, Restivo V et al (2018) Mild cognitive impairment in Parkinson’s disease. The Parkinson’s disease cognitive study (PACOS). J Neurol 265:1050–1058. https://doi.org/10.1007/s00415-018-8800-4$$v265$$y2018
000155574 999C5 $$1D Wiesli$$2Crossref$$9-- missing cx lookup --$$a10.1159/000478849$$p297 -$$tDement Geriatr Cogn Dis Extra$$uWiesli D, Meyer A, Fuhr P, Gschwandtner U (2017) Influence of Mild cognitive impairment, depression, and anxiety on the quality of life of patients with Parkinson disease. Dement Geriatr Cogn Dis Extra 7:297–308. https://doi.org/10.1159/000478849$$v7$$y2017
000155574 999C5 $$1LML de Lau$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.parkreldis.2014.02.030$$p613 -$$tParkinsonism Relat Disord$$ude Lau LML, Verbaan D, Marinus J, van Hilten JJ (2014) Survival in Parkinson’s disease. Relation with motor and non-motor features. Parkinsonism Relat Disord 20:613–616. https://doi.org/10.1016/j.parkreldis.2014.02.030$$v20$$y2014
000155574 999C5 $$1M Rolinski$$2Crossref$$9-- missing cx lookup --$$a10.1002/14651858.CD006504.pub2$$tCochrane Database Syst Rev$$uRolinski M, Fox C, Maidment I, McShane R (2012) Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD006504.pub2$$y2012
000155574 999C5 $$1R McShane$$2Crossref$$9-- missing cx lookup --$$a10.1002/14651858.CD003154.pub6$$pCD003154 -$$tCochrane Database Syst Rev$$uMcShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE et al (2019) Memantine for dementia. Cochrane Database Syst Rev 3:CD003154. https://doi.org/10.1002/14651858.CD003154.pub6$$v3$$y2019
000155574 999C5 $$1IHK Leung$$2Crossref$$9-- missing cx lookup --$$a10.1212/WNL.0000000000002145$$p1843 -$$tNeurology$$uLeung IHK, Walton CC, Hallock H, Lewis SJG, Valenzuela M, Lampit A (2015) Cognitive training in Parkinson disease. A systematic review and meta-analysis. Neurology 85:1843–1851. https://doi.org/10.1212/WNL.0000000000002145$$v85$$y2015
000155574 999C5 $$1BJ Lawrence$$2Crossref$$9-- missing cx lookup --$$a10.1177/1545968317712468$$p597 -$$tNeurorehabil Neural Repair$$uLawrence BJ, Gasson N, Bucks RS, Troeung L, Loftus AM (2017) Cognitive training and noninvasive brain stimulation for cognition in Parkinson’s disease: a meta-analysis. Neurorehabil Neural Repair 31:597–608. https://doi.org/10.1177/1545968317712468$$v31$$y2017
000155574 999C5 $$1M Pupíková$$2Crossref$$9-- missing cx lookup --$$a10.1007/s00702-019-02113-w$$p799 -$$tJ Neural Transm$$uPupíková M, Rektorová I (2020) Non-pharmacological management of cognitive impairment in Parkinson’s disease. J Neural Transm 127:799–820. https://doi.org/10.1007/s00702-019-02113-w$$v127$$y2020
000155574 999C5 $$1V Orgeta$$2Crossref$$9-- missing cx lookup --$$a10.1002/14651858.CD011961.pub2$$tCochrane Database Syst Rev$$uOrgeta V, McDonald KR, Poliakoff E, Hindle JV, Clare L, Leroi I (2020) Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s disease. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD011961.pub2$$y2020
000155574 999C5 $$1JD Edwards$$2Crossref$$9-- missing cx lookup --$$a10.1212/WNL.0b013e3182a823ba$$p1284 -$$tNeurology$$uEdwards JD, Hauser RA, O’Connor ML, Valdés EG, Zesiewicz TA, Uc EY (2013) Randomized trial of cognitive speed of processing training in Parkinson disease. Neurology 81:1284–1290. https://doi.org/10.1212/WNL.0b013e3182a823ba$$v81$$y2013
000155574 999C5 $$1D Fellman$$2Crossref$$9-- missing cx lookup --$$a10.1080/09602011.2018.1489860$$p673 -$$tNeuropsychol Rehabil$$uFellman D, Salmi J, Ritakallio L, Ellfolk U, Rinne JO, Laine M (2020) Training working memory updating in Parkinson’s disease. A randomised controlled trial. Neuropsychol Rehabil 30:673–708. https://doi.org/10.1080/09602011.2018.1489860$$v30$$y2020
000155574 999C5 $$1R Zimmermann$$2Crossref$$9-- missing cx lookup --$$a10.1212/WNL.0000000000000287$$p1219 -$$tNeurology$$uZimmermann R, Gschwandtner U, Benz N, Hatz F, Schindler C, Taub E et al (2014) Cognitive training in Parkinson disease. Cognition-specific vs nonspecific computer training. Neurology 82:1219–1226. https://doi.org/10.1212/WNL.0000000000000287$$v82$$y2014
000155574 999C5 $$1AP París$$2Crossref$$9-- missing cx lookup --$$a10.1002/mds.23688$$p1251 -$$tMov Disord$$uParís AP, Saleta HG, de La Cruz Crespo Maraver M, Silvestre E, Freixa MG, Torrellas CP et al (2011) Blind randomized controlled study of the efficacy of cognitive training in Parkinson’s disease. Mov Disord 26:1251–1258. https://doi.org/10.1002/mds.23688$$v26$$y2011
000155574 999C5 $$1A Ophey$$2Crossref$$9-- missing cx lookup --$$a10.1177/1545968320981956$$p117 -$$tNeurorehabil Neural Repair$$uOphey A, Rehberg S, Giehl K, Eggers C, Reker P, van Eimeren T et al (2021) Predicting working memory training responsiveness in Parkinson’s disease: both “System Hardware” and room for improvement are needed. Neurorehabil Neural Repair 35:117–130. https://doi.org/10.1177/1545968320981956$$v35$$y2021
000155574 999C5 $$1E Kalbe$$2Crossref$$9-- missing cx lookup --$$a10.1155/2020/4068706$$p1 -$$tParkinson’s Disease$$uKalbe E, Folkerts A-K, Ophey A, Eggers C, Elben S, Dimenshteyn K et al (2020) Enhancement of executive functions but not memory by multidomain group cognitive training in patients with Parkinson’s disease and mild cognitive impairment: a multicenter randomized controlled trial. Parkinson’s Disease 2020:1–15. https://doi.org/10.1155/2020/4068706$$v2020$$y2020
000155574 999C5 $$1AJ Hughes$$2Crossref$$9-- missing cx lookup --$$a10.1136/jnnp.55.3.181$$p181 -$$tJ Neurol Neurosurg Psychiatr$$uHughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatr 55:181–184. https://doi.org/10.1136/jnnp.55.3.181$$v55$$y1992
000155574 999C5 $$1I Litvan$$2Crossref$$9-- missing cx lookup --$$a10.1002/mds.24893$$p349 -$$tMov Disord$$uLitvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: movement disorder society task force guidelines. Mov Disord 27:349–356. https://doi.org/10.1002/mds.24893$$v27$$y2012
000155574 999C5 $$1F Jessen$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.jalz.2012.09.017$$p76 -$$tAlzheimer’s Dementia$$uJessen F, Wolfsgruber S, Wiese B, Bickel H, Mösch E, Kaduszkiewicz H et al (2014) AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimer’s Dementia 10:76–83. https://doi.org/10.1016/j.jalz.2012.09.017$$v10$$y2014
000155574 999C5 $$1ZS Nasreddine$$2Crossref$$9-- missing cx lookup --$$a10.1111/j.1532-5415.2005.53221.x$$p695 -$$tJ Am Geriatr Soc$$uNasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x$$v53$$y2005
000155574 999C5 $$1M Emre$$2Crossref$$9-- missing cx lookup --$$a10.1002/mds.21507$$p1689 -$$tMov Disord$$uEmre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707. https://doi.org/10.1002/mds.21507$$v22$$y2007
000155574 999C5 $$1B Dubois$$2Crossref$$9-- missing cx lookup --$$a10.1002/mds.21844$$p2314 -$$tMov Disord$$uDubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA et al (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324. https://doi.org/10.1002/mds.21844$$v22$$y2007
000155574 999C5 $$1AT Beck$$2Crossref$$tManual for the Beck depression inventory-II$$uBeck AT, Steer RA, Brown GK (1996) Manual for the Beck depression inventory-II. Psychological Corporation, San Antonio, TX, USA$$y1996
000155574 999C5 $$1G Baller$$2Crossref$$tNeurovitalis. ein neuropsychologisches Gruppenprogramm zur Förderung der geistigen Leistungsfähigkeit$$uBaller G, Kalbe E, Kaesberg S, Kessler J (2009) Neurovitalis: ein neuropsychologisches Gruppenprogramm zur Förderung der geistigen Leistungsfähigkeit. ProLog, Cologne, Germany$$y2009
000155574 999C5 $$1G Baller$$2Crossref$$tNEUROvitalis Parkinson: ein wissenschaftlich fundiertes Gruppenprogramm zur Förderung der geistigen Leistungsfähigkeit bei Morbus Parkinson Patienten$$uBaller G, Folkerts AK, Kessler J, Kalbe E (2021) NEUROvitalis Parkinson: ein wissenschaftlich fundiertes Gruppenprogramm zur Förderung der geistigen Leistungsfähigkeit bei Morbus Parkinson Patienten. ProLog, Cologne, Germany$$y2021
000155574 999C5 $$1H Niemann$$2Crossref$$tCVLT. California Verbal Learning Test. Deutsche Adaptation$$uNiemann H, Sturm W, Thöne-Otto A, Willmes K (2008) CVLT. California Verbal Learning Test. Deutsche Adaptation. Pearson, Frankfurt am Main$$y2008
000155574 999C5 $$1E Strauss$$2Crossref$$tCompendium of neuropsychological tests: administration, norms and commentary$$uStrauss E, Sherman EMS, Spreen O (2006) Compendium of neuropsychological tests: administration, norms and commentary. Oxford University Press, New York, NY$$y2006
000155574 999C5 $$1S Aschenbrenner$$2Crossref$$tRegensburger Wortflüssigkeits-Test: RWT$$uAschenbrenner S, Tucha O, Lange KW (2000) Regensburger Wortflüssigkeits-Test: RWT. Hogrefe, Göttingen$$y2000
000155574 999C5 $$1DJ Schretlen$$2Crossref$$tM-WCST, Modified Wisconsin Card Sorting Test$$uSchretlen DJ (2011) M-WCST, Modified Wisconsin Card Sorting Test. Psychological Assessment Resources, Lutz, FL$$y2011
000155574 999C5 $$1BA Wilson$$2Crossref$$tBehavioural Assessment of the Dysexecutive Syndrome (BADS)$$uWilson BA, Emslie H, Evans JJ, Alderman N, Burgess PW (1991) Behavioural Assessment of the Dysexecutive Syndrome (BADS). Pearson, London$$y1991
000155574 999C5 $$1R Brickenkamp$$2Crossref$$tTest d2—revision. Aufmerksamkeits- und konzentrationstest$$uBrickenkamp R, Schmidt-Atzert L, Liepmann D (2010) Test d2—Revision. Aufmerksamkeits- und Konzentrationstest. Hogrefe, Göttingen$$y2010
000155574 999C5 $$1D Wechsler$$2Crossref$$tWechsler adult intelligence scale—third edition (WAIS-III)$$uWechsler D (1997) Wechsler adult intelligence scale—third edition (WAIS-III). Pearson, London$$y1997
000155574 999C5 $$1AL Benton$$2Crossref$$tBenton judgement of line orientation$$uBenton AL, Sivan AB, Hamsher K, Varney NR, Spreen O (1983) Benton judgement of line orientation. Psychological Assessment Resources, Lutz, FL$$y1983
000155574 999C5 $$1JC Morris$$2Crossref$$9-- missing cx lookup --$$a10.1212/wnl.39.9.1159$$p1159 -$$tNeurology$$uMorris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G et al (1989) The consortium to establish a registry for Alzheimer’s disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 39:1159–1165. https://doi.org/10.1212/wnl.39.9.1159$$v39$$y1989
000155574 999C5 $$1E Kalbe$$2Crossref$$tACL—Aphasie-Check-Liste$$uKalbe E, Reinhold N, Ender U, Kessler J (2010) ACL—Aphasie-Check-Liste. ProLog, Cologne$$y2010
000155574 999C5 $$1H Erzigkeit$$2Crossref$$tBayer ADL-Skala. Eine Skala zur Erfassung von Beeinträchtigungen der Alltagskompetenz bei älteren Patienten mit Einbußen der kognitiven Leistungsfähigkeit$$uErzigkeit H, Lehfeld H (2010) Bayer ADL-Skala. Eine Skala zur Erfassung von Beeinträchtigungen der Alltagskompetenz bei älteren Patienten mit Einbußen der kognitiven Leistungsfähigkeit. Pearson, Frankfurt am Main$$y2010
000155574 999C5 $$1RA Washburn$$2Crossref$$9-- missing cx lookup --$$a10.1016/0895-4356(93)90053-4$$p153 -$$tJ Clin Epidemiol$$uWashburn RA, Smith KW, Jette AM, Janney CA (1993) The physical activity scale for the elderly (PASE): development and evaluation. J Clin Epidemiol 46:153–162. https://doi.org/10.1016/0895-4356(93)90053-4$$v46$$y1993
000155574 999C5 $$1C Jenkinson$$2Crossref$$9-- missing cx lookup --$$a10.1093/ageing/26.5.353$$p353 -$$tAge Ageing$$uJenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N (1997) The Parkinson’s disease questionnaire (PDQ-39). Development and validation of a Parkinson’s disease summary index score. Age Ageing 26:353–357. https://doi.org/10.1093/ageing/26.5.353$$v26$$y1997
000155574 999C5 $$1P Zimmermann$$2Crossref$$tEin Fragebogen erlebter Defizite der Aufmerksamkeit (FEDA)$$uZimmermann P, Merser C, Poser U, Sedelmeier P (1991) Ein Fragebogen erlebter Defizite der Aufmerksamkeit (FEDA). University Institute of Psychology, Freiburg$$y1991
000155574 999C5 $$1Fahn S, Elton RL, Members of the UPDRS development committee$$2Crossref$$tRecent developments in Parkinson’s disease$$uFahn S, Elton RL, Members of the UPDRS development committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB et al (eds) Recent developments in Parkinson’s disease, vol 2. Macmillan Health Care Information. Florham Park, NJ, pp 153–164$$y1987
000155574 999C5 $$1N Giladi$$2Crossref$$9-- missing cx lookup --$$a10.1016/s1353-8020(99)00062-0$$p165 -$$tParkinsonism Relat Disord$$uGiladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD (2000) Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 6:165–170. https://doi.org/10.1016/s1353-8020(99)00062-0$$v6$$y2000
000155574 999C5 $$1J Cohen$$2Crossref$$tStatistical power analysis for the behavioral sciences$$uCohen J (1977) Statistical power analysis for the behavioral sciences. Academic Press, New York, NY$$y1977
000155574 999C5 $$1JBS Langbaum$$2Crossref$$9-- missing cx lookup --$$a10.1093/geronb/gbn026$$p14 -$$tJ Gerontol B Psychol Sci Soc Sci$$uLangbaum JBS, Rebok GW, Bandeen-Roche K, Carlson MC (2009) Predicting memory training response patterns: results from ACTIVE. J Gerontol B Psychol Sci Soc Sci 64:14–23. https://doi.org/10.1093/geronb/gbn026$$v64$$y2009
000155574 999C5 $$1L Jean$$2Crossref$$9-- missing cx lookup --$$a10.1080/09602010903343012$$p377 -$$tNeuropsychol Rehabil$$uJean L, Simard M, Wiederkehr S, Bergeron M-E, Turgeon Y, Hudon C et al (2010) Efficacy of a cognitive training programme for mild cognitive impairment: results of a randomised controlled study. Neuropsychol Rehabil 20:377–405. https://doi.org/10.1080/09602010903343012$$v20$$y2010
000155574 999C5 $$1LA Whitlock$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.chb.2012.01.012$$p1091 -$$tComput Hum Behav$$uWhitlock LA, McLaughlin AC, Allaire JC (2012) Individual differences in response to cognitive training: using a multi-modal, attentionally demanding game-based intervention for older adults. Comput Hum Behav 28:1091–1096. https://doi.org/10.1016/j.chb.2012.01.012$$v28$$y2012
000155574 999C5 $$1JK Fairchild$$2Crossref$$9-- missing cx lookup --$$a10.1017/S1041610212002049$$p607 -$$tInt Psychogeriatr$$uFairchild JK, Friedman L, Rosen AC, Yesavage JA (2013) Which older adults maintain benefit from cognitive training? Use of signal detection methods to identify long-term treatment gains. Int Psychogeriatr 25:607–616. https://doi.org/10.1017/S1041610212002049$$v25$$y2013
000155574 999C5 $$1GW Rebok$$2Crossref$$9-- missing cx lookup --$$a10.1177/0898264312461937$$p21S -$$tJ Aging Health$$uRebok GW, Langbaum JBS, Jones RN, Gross AL, Parisi JM, Spira AP et al (2013) Memory training in the ACTIVE study: how much is needed and who benefits? J Aging Health 25:21S-42S. https://doi.org/10.1177/0898264312461937$$v25$$y2013
000155574 999C5 $$1J Rahe$$2Crossref$$9-- missing cx lookup --$$a10.3389/fnagi.2015.00187$$p187 -$$tFront Aging Neurosci$$uRahe J, Becker J, Fink GR, Kessler J, Kukolja J, Rahn A et al (2015) Cognitive training with and without additional physical activity in healthy older adults: cognitive effects, neurobiological mechanisms, and prediction of training success. Front Aging Neurosci 7:187. https://doi.org/10.3389/fnagi.2015.00187$$v7$$y2015
000155574 999C5 $$1M Roheger$$2Crossref$$9-- missing cx lookup --$$a10.1002/brb3.1861$$pe01861 -$$tBrain Behav$$uRoheger M, Kalbe E, Corbett A, Brooker H, Ballard C (2020) Predictors of changes after reasoning training in healthy adults. Brain Behav 10:e01861. https://doi.org/10.1002/brb3.1861$$v10$$y2020
000155574 999C5 $$1M Roheger$$2Crossref$$9-- missing cx lookup --$$a10.1080/13825585.2019.1617396$$p351 -$$tNeuropsychol Dev Cogn B Aging Neuropsychol Cogn$$uRoheger M, Meyer J, Kessler J, Kalbe E (2020) Predicting short- and long-term cognitive training success in healthy older adults: who benefits? Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 27:351–369. https://doi.org/10.1080/13825585.2019.1617396$$v27$$y2020
000155574 999C5 $$1E Kalbe$$2Crossref$$9-- missing cx lookup --$$a10.1136/jnnp-2016-313838$$p1099 -$$tJ Neurol Neurosurg Psychiatry$$uKalbe E, Rehberg SP, Heber I, Kronenbuerger M, Schulz JB, Storch A et al (2016) Subtypes of mild cognitive impairment in patients with Parkinson’s disease: evidence from the LANDSCAPE study. J Neurol Neurosurg Psychiatry 87:1099–1105. https://doi.org/10.1136/jnnp-2016-313838$$v87$$y2016
000155574 999C5 $$1J Peña$$2Crossref$$9-- missing cx lookup --$$a10.1212/WNL.0000000000001043$$p2167 -$$tNeurology$$uPeña J, Ibarretxe-Bilbao N, García-Gorostiaga I, Gomez-Beldarrain MA, Díez-Cirarda M, Ojeda N (2014) Improving functional disability and cognition in Parkinson disease: randomized controlled trial. Neurology 83:2167–2174. https://doi.org/10.1212/WNL.0000000000001043$$v83$$y2014
000155574 999C5 $$1A Petrelli$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.parkreldis.2014.08.023$$p1196 -$$tParkinsonism Relat Disord$$uPetrelli A, Kaesberg S, Barbe MT, Timmermann L, Fink GR, Kessler J et al (2014) Effects of cognitive training in Parkinson’s disease: a randomized controlled trial. Parkinsonism Relat Disord 20:1196–1202. https://doi.org/10.1016/j.parkreldis.2014.08.023$$v20$$y2014
000155574 999C5 $$1A Alloni$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.ijmedinf.2018.04.005$$p64 -$$tInt J Med Inform$$uAlloni A, Quaglini S, Panzarasa S, Sinforiani E, Bernini S (2018) Evaluation of an ontology-based system for computerized cognitive rehabilitation. Int J Med Inform 115:64–72. https://doi.org/10.1016/j.ijmedinf.2018.04.005$$v115$$y2018
000155574 999C5 $$1BJ Lawrence$$2Crossref$$9-- missing cx lookup --$$a10.1155/2018/4318475$$p4318475 -$$tParkinson’s Disease$$uLawrence BJ, Gasson N, Johnson AR, Booth L, Loftus AM (2018) Cognitive training and transcranial direct current stimulation for mild cognitive impairment in Parkinson’s disease: a randomized controlled trial. Parkinson’s Disease 2018:4318475. https://doi.org/10.1155/2018/4318475$$v2018$$y2018
000155574 999C5 $$1CI Higginson$$2Crossref$$9-- missing cx lookup --$$a10.1016/S0278-2626(03)00180-5$$p343 -$$tBrain Cogn$$uHigginson CI, King DS, Levine D, Wheelock VL, Khamphay NO, Sigvardt KA (2003) The relationship between executive function and verbal memory in Parkinson’s disease. Brain Cogn 52:343–352. https://doi.org/10.1016/S0278-2626(03)00180-5$$v52$$y2003
000155574 999C5 $$1TJ O’Brien$$2Crossref$$9-- missing cx lookup --$$a10.1093/arclin/acp029$$p237 -$$tArch Clin Neuropsychol$$uO’Brien TJ, Wadley V, Nicholas AP, Stover NP, Watts R, Griffith HR (2009) The contribution of executive control on verbal-learning impairment in patients with Parkinson’s disease with dementia and Alzheimer’s disease. Arch Clin Neuropsychol 24:237–244. https://doi.org/10.1093/arclin/acp029$$v24$$y2009
000155574 999C5 $$1BD Hill$$2Crossref$$9-- missing cx lookup --$$a10.1080/09084282.2011.643960$$p198 -$$tAppl Neuropsychol Adult$$uHill BD, Alosco M, Bauer L, Tremont G (2012) The relation of executive functioning to CVLT-II learning, memory, and process indexes. Appl Neuropsychol Adult 19:198–206. https://doi.org/10.1080/09084282.2011.643960$$v19$$y2012
000155574 999C5 $$1BL Brooks$$2Crossref$$9-- missing cx lookup --$$a10.1080/13854040590947461$$p230 -$$tClin Neuropsychol$$uBrooks BL, Weaver LE, Scialfa CT (2006) Does impaired executive functioning differentially impact verbal memory measures in older adults with suspected dementia? Clin Neuropsychol 20:230–242. https://doi.org/10.1080/13854040590947461$$v20$$y2006
000155574 999C5 $$1MP Alexander$$2Crossref$$9-- missing cx lookup --$$a10.1093/brain/awg128$$p1493 -$$tBrain$$uAlexander MP, Stuss DT, Fansabedian N (2003) California Verbal Learning Test: performance by patients with focal frontal and non-frontal lesions. Brain 126:1493–1503. https://doi.org/10.1093/brain/awg128$$v126$$y2003
000155574 999C5 $$1JS Janowsky$$2Crossref$$9-- missing cx lookup --$$a10.1080/01688639308402554$$p159 -$$tJ Clin Exp Neuropsychol$$uJanowsky JS, Thomas-Thrapp LJ (1993) Complex figure recall in the elderly: a deficit in memory or constructional strategy? J Clin Exp Neuropsychol 15:159–169. https://doi.org/10.1080/01688639308402554$$v15$$y1993
000155574 999C5 $$1H Westervelt$$2Crossref$$9-- missing cx lookup --$$a10.1016/S0887-6177(00)80060-8$$p684 -$$tArch Clin Neuropsychol$$uWestervelt H (2000) The impact of organizational strategy on recall of the Rey-Osterrieth complex figure. Arch Clin Neuropsychol 15:684. https://doi.org/10.1016/S0887-6177(00)80060-8$$v15$$y2000
000155574 999C5 $$1V Moro$$2Crossref$$9-- missing cx lookup --$$a10.1177/1533317514539542$$p153 -$$tAm J Alzheimers Dis Other Demen$$uMoro V, Condoleo MT, Valbusa V, Broggio E, Moretto G, Gambina G (2015) Cognitive stimulation of executive functions in mild cognitive impairment: specific efficacy and impact in memory. Am J Alzheimers Dis Other Demen 30:153–164. https://doi.org/10.1177/1533317514539542$$v30$$y2015
000155574 999C5 $$1PL Yudkin$$2Crossref$$9-- missing cx lookup --$$a10.1016/S0140-6736(96)90410-9$$p241 -$$tThe Lancet$$uYudkin PL, Stratton IM (1996) How to deal with regression to the mean in intervention studies. The Lancet 347:241–243. https://doi.org/10.1016/S0140-6736(96)90410-9$$v347$$y1996